Collagen XXIV (Col24a1) promotes osteoblastic differentiation and mineralization through TGF-β/smads signaling pathway

International Journal of Biological Sciences

Volumn 8, Issue 10, 2012, Pages 1310-1322

  Wang, Weizhuo ^a,b   Olson, Douglas ^a   Liang, Gang ^a   Franceschi, Renny T ^c   Li, Chunyi ^a   Wang, Bingyan ^d   Wang, Shuen Shiuan ^a   Yang, Shuying ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Bone mineralization; COLLAGEN XXIV; Integrin; Osteoblast differentiation; SMAD

Indexed keywords

LENTIVIRUS; MURINAE;

BETA3 INTEGRIN; COLLAGEN; COLLAGEN TYPE XXIV; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; MOUSE; OSTEOBLAST; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; COLLAGEN; GENE EXPRESSION REGULATION; GENE SILENCING; INTEGRIN BETA3; MICE; OSTEOBLASTS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84869785646     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.5136     Document Type: Article

References (62)

1. Ricard-Blum S, Ruggiero F. The collagen superfamily: from the extracellular matrix to the cell membrane. Pathol Biol (Paris). 2005; 53: 430-442. doi:S0369-8114(04)00313-X [pii] 10.1016/j.patbio.2004.12.024.
2. Golub EE. Role of matrix vesicles in biomineralization. Biochim Biophys Acta. 2009; 1790: 1592-1598. doi:S0304-4165(09)00268-2 [pii] 10.1016/j.bbagen.2009.09.006.
3. Anderson HC, Garimella R, Tague SE. The role of matrix vesicles in growth plate development and biomineralization. Front Biosci. 2005; 10: 822-837.
4. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, et al. Increased bone formation in osteocalcin-deficient mice. Nature. 1996; 382: 448-452. doi:10.1038/382448a0.
5. Chung KS, Jacenko O, Boyle P, Olsen BR, Nishimura I. Craniofacial abnormalities in mice carrying a dominant interference mutation in type X collagen. Dev Dyn. 1997; 208: 544-552.
6. Savontaus M, Rintala-Jamsa M, Morko J, Ronning O, Metsaranta M, Vuorio E. Abnormal craniofacial development and expression patterns of extracellular matrix components in transgenic Del1 mice harboring a deletion mutation in the type II collagen gene. Orthod Craniofac Res. 2004; 7: 216-226.
7. Spranger J, Menger H, Mundlos S, Winterpacht A, Zabel B. Kniest dysplasia is caused by dominant collagen II (COL2A1) mutations: parental somatic mosaicism manifesting as Stickler phenotype and mild spondyloepiphyseal dysplasia. Pediatr Radiol. 1994; 24: 431-435.
8. Wang WZ, Guo X, Duan C, Ma WJ, Zhang YG, Xu P, et al. Comparative analysis of gene expression profiles between the normal human cartilage and the one with endemic osteoarthritis. Osteoarthritis Cartilage. 2009; 17: 83-90. doi:S1063-4584(08)00170-2 [pii] 10.1016/j.joca.2008.05.008.
9. Wang W, Guo X, Chen J, Xu P, Lammi MJ. Morphology and phenotype expression of types I, II, III, and X collagen and MMP-13 of chondrocytes cultured from articular cartilage of Kashin-Beck Disease. J Rheumatol. 2008; 35: 696-702. doi:08/13/0313 [pii].
10. Gordon MK, Hahn RA. Collagens. Cell Tissue Res. 2010; 339: 247-257. doi:10.1007/s00441-009-0844-4.
11. Dunsmore SE, Geoffrey JL, Steven DS. Extracellular matrix: Collagens; Encyclopedia of Respiratory Medicine. Oxford: Academic Press. 2006: 168-175.
12. Margadant C, Sonnenberg A. Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep. 2010; 11: 97-105. doi:embor2009276 [pii] 10.1038/embor.2009.276.
13. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002; 110: 673-687. doi:S0092867402009716 [pii].
14. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992; 69: 11-25. doi:0092-8674(92)90115-S [pii].
15. Schaffner P, Dard MM. Structure and function of RGD peptides involved in bone biology. Cell Mol Life Sci. 2003; 60: 119-132.
16. Reynolds LE, Conti FJ, Silva R, Robinson SD, Iyer V, Rudling R, et al. alpha3beta1 integrin-controlled Smad7 regulates reepithelialization during wound healing in mice. J Clin Invest. 2008; 118: 965-974. doi:10.1172/JCI33538.
17. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996; 12: 697-715. doi:10.1146/annurev.cellbio.12.1.697.
18. Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Eur J Cell Biol. 2008; 87: 601-615. doi:10.1016/j.ejcb.2008.01.012.
19. Scotton CJ, Krupiczojc MA, Konigshoff M, Mercer PF, Lee YC, Kaminski N, et al. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest. 2009; 119: 2550-2563. doi:10.1172/JCI33288.
20. Asano Y, Ihn H, Jinnin M, Mimura Y, Tamaki K. Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma. J Invest Dermatol. 2006; 126: 1761-1769. doi:10.1038/sj.jid.5700331.
21. Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. J Immunol. 2005; 175: 7708-7718.
22. Yang Z, Mu Z, Dabovic B, Jurukovski V, Yu D, Sung J, et al. Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J Cell Biol. 2007; 176: 787-793. doi:10.1083/jcb.200611044.
23. Nykvist P, Tasanen K, Viitasalo T, Kapyla J, Jokinen J, Bruckner-Tuderman L, et al. The cell adhesion domain of type XVII collagen promotes integrin-mediated cell spreading by a novel mechanism. J Biol Chem. 2001; 276: 38673-38679. doi:10.1074/jbc.M102589200 M102589200 [pii].
24. Koch M, Laub F, Zhou P, Hahn RA, Tanaka S, Burgeson RE, et al. Collagen XXIV, a vertebrate fibrillar collagen with structural features of invertebrate collagens: selective expression in developing cornea and bone. J Biol Chem. 2003; 278: 43236-43244. doi:10.1074/jbc.M302112200 M302112200 [pii].
25. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. Journal of Bone and Mineral Research. 1999; 14: 893-903. doi:10.1359/jbmr.1999.14.6.893.
26. He X, Dziak R, Mao K, Genco R, Swihart M, Li C, et al. Integration of a novel injectable nano calcium sulfate/alginate scaffold and BMP2-gene modified MSCs for bone regeneration. Tissue Eng Part A. 2012. doi:10.1089/ten.TEA.2012.0244.
27. Yang SY, Wei DY, Wang D, Phimphilai M, Krebsbach PH, Franceschi RT. In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. Journal of Bone and Mineral Research. 2003; 18: 705-715.
28. Liu S, Tang W, Fang J, Ren J, Li H, Xiao Z, et al. Novel regulators of Fgf23 expression and mineralization in Hyp bone. Mol Endocrinol. 2009; 23: 1505-1518. doi:10.1210/me.2009-0085.
29. Yang S, Wang C. The intraflagellar transport protein IFT80 is required for cilia formation and osteogenesis. Bone. 2012; 51: 407-417. doi:10.1016/j.bone.2012.06.021.
30. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA. 2003; 9: 493-501.
31. Yang S, Li YP. RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation. Genes Dev. 2007; 21: 1803-1816. doi:gad.1544107 [pii] 10.1101/gad.1544107.
32. Schneider GB, Whitson SW, Cooper LF. Restricted and coordinated expression of beta3-integrin and bone sialoprotein during cultured osteoblast differentiation. Bone. 1999; 24: 321-327. doi:S8756-3282(99)00007-1 [pii].
33. Ovchinnikov D. Alcian blue/alizarin red staining of cartilage and bone in mouse. Cold Spring Harb Protoc. 2009; doi:2009/3/pdb.prot5170 [pii] 10.1101/pdb.prot5170.
34. Yamakawa K, Iwasaki H, Masuda I, Ohjimi Y, Honda I, Saeki K, et al. The utility of alizarin red s staining in calcium pyrophosphate dihydrate crystal deposition disease. J Rheumatol. 2003; 30: 1032-1035. doi:0315162X-30-1032 [pii].
35. Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN, et al. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res. 2000; 60: 6001-6007.
36. Rungby J, Kassem M, Eriksen EF, Danscher G. The von Kossa reaction for calcium deposits: silver lactate staining increases sensitivity and reduces background. Histochem J. 1993; 25: 446-451.
37. McCauley LK, Koh AJ, Beecher CA, Cui Y, Decker JD, Franceschi RT. Effects of differentiation and transforming growth factor beta 1 onPTH/PTHrP receptor mRNA levels in MC3T3-E1 cells. Journal of Bone and Mineral Research. 1995; 10: 1243-1255. doi:10.1002/jbmr.5650100815.
38. Yang SY, Chen W, Stashenko P, Li YP. Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation. Journal of Cell Science. 2007; 120: 3362-3371. doi:Doi 10.1242/Jcs.008300.
39. Hamidouche Z, Fromigue O, Ringe J, Haupl T, Vaudin P, Pages JC, et al. Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis. Proc Natl Acad Sci USA. 2009; 106: 18587-18591. doi:0812334106 [pii]10.1073/pnas.0812334106.
40. Steenhard BM, Isom K, Stroganova L, St John PL, Zelenchuk A, Freeburg PB, et al. Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen {alpha}1{alpha}2{alpha}1(IV), expression of neuroglobin, and proteinuria. Am J Pathol. 2010; 177: 84-96. doi:ajpath.2010.090767 [pii] 10.2353/ajpath.2010.090767.
41. Orimo H. The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch. 2010; 77: 4-12. doi:JST.JSTAGE/jnms/77.4 [pii].
42. Kim DS, Jeon OH, Lee HD, Yoo KH. Integrin alphavbeta3-mediated transcriptional regulation of TIMP-1 in a human ovarian cancer cell line. Biochem Biophys Res Commun. 2008; 377: 479-483. doi:S0006-291X(08)01960-8 [pii] 10.1016/j.bbrc.2008.10.010.
43. Reed RK, Rubin K. Transcapillary exchange: role and importance of the interstitial fluid pressure and the extracellular matrix. Cardiovasc Res. 2010; 87: 211-217. doi:cvq143 [pii]10.1093/cvr/cvq143.
44. Hughes DE, Salter DM, Dedhar S, Simpson R. Integrin expression in human bone. Journal of Bone and Mineral Research. 1993; 8: 527-533. doi:10.1002/jbmr.5650080503.
45. Gronthos S, Stewart K, Graves SE, Hay S, Simmons PJ. Integrin expression and function on human osteoblast-like cells. Journal of Bone and Mineral Research. 1997; 12: 1189-1197. doi:10.1359/jbmr.1997.12.8.1189.
46. Grzesik WJ, Robey PG. Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro. Journal of Bone and Mineral Research. 1994; 9: 487-496. doi:10.1002/jbmr.5650090408.
47. Scarborough RM, Rose JW, Hsu MA, Phillips DR, Fried VA, Campbell AM, et al. Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J Biol Chem. 1991; 266: 9359-9362.
48. Matsuo N, Tanaka S, Yoshioka H, Koch M, Gordon MK, Ramirez F. Collagen XXIV (Col24a1) gene expression is a specific marker of osteoblast differentiation and bone formation. Connect Tissue Res. 2008; 49: 68-75. doi:791857477 [pii] 10.1080/03008200801913502.
49. Beresford JN, Graves SE, Smoothy CA. Formation of mineralized nodules by bone derived cells in vitro: a model of bone formation? Am J Med Genet. 1993; 45: 163-178. doi:10.1002/ajmg.1320450205.
50. Stein GS, Lian JB, Owen TA. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 1990; 4: 3111-3123.
51. Shi S, Kirk M, Kahn AJ. The role of type I collagen in the regulation of the osteoblast phenotype. Journal of Bone and Mineral Research. 1996; 11: 1139-1145. doi:10.1002/jbmr.5650110813.
52. Lynch MP, Stein JL, Stein GS, Lian JB. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res. 1995; 216: 35-45. doi:S0014-4827(85)71005-1 [pii] 10.1006/excr.1995.1005.
53. Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol. 1990; 143: 213-221. doi:10.1002/jcp.1041430203.
54. Chen G, Deng C, Li YP. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci. 2012; 8: 272-288. doi:10.7150/ijbs.2929.
55. Ito Y, Yeo JY, Chytil A, Han J, Bringas P, Jr., Nakajima A, et al. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development. 2003; 130: 5269-5280. doi:10.1242/dev.00708 130/21/5269 [pii].
56. Chai Y, Ito Y, Han J. TGF-beta signaling and its functional significance in regulating the fate of cranial neural crest cells. Crit Rev Oral Biol Med. 2003; 14: 78-88. doi:14/2/78 [pii].
57. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Bio. 2000; 1: 169-178.
58. Munger JS, Sheppard D. Cross talk among TGF-beta signaling pathways, integrins, and the extracellular matrix. Cold Spring Harbor perspectives in biology. 2011; 3: a005017. doi:10.1101/cshperspect.a005017.
59. Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J Biol Chem. 2001; 276: 46707-46713. doi:10.1074/jbc.M106176200.
60. Seo HS, Serra R. Tgfbr2 is required for development of the skull vault. Dev Biol. 2009; 334: 481-490. doi:10.1016/j.ydbio.2009.08.015.
61. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 1997; 389: 631-635. doi:10.1038/39369.
62. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, et al. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell. 1997; 89: 1165-1173. doi:S0092-8674(00)80303-7 [pii].